10th
Congress of the European Society of Contraception
| Scientific
programme in detail |
|||
| Wednesday,
April 30 |
Thursday,
May 1 |
Friday,
May 2 |
Saturday,
May 3 |
overview>>>
| 08:30 – 10:00 | 10:30
– 12:00 |
12:15 – 13:15 | 13:30 –
16:00 |
16:30 – 18:00 |
| 13:30 – 14:00 |
Congress Hall |
Keynote
Lecture 2 |
|
| Chair: P. Krepelka (Czech Rep.) | |||
| Risk of DVT with new molecules – Ø.
Lidegaard (Denmark) |
|||
|
|||
| 14:00 – 15:30 | Congress Hall | Sponsored
Symposium 4 (Bayer Schering Pharma) : New research:important data for counselling your OC patients |
|
| Chair: M. Cronin (Bayer Schering Pharma) | |||
| Bayer Schering Pharma: Taking a leading role in woman´s
health research – M. Cronin (Bayer Schering Pharma) |
|||
| EURAS: the largest European active surveillance study on
the safety and efficacy of OC us – J. Dinger (Germany |
|||
| Two new major studies on the protective effect of OC use
on ovarian and endometrial cancer – TBD |
|||
| Putting the new data into perspective for your OC patient
– L. Shulman (USA) |
|||
|
|
|||
| 14:00 – 15:30 |
Meeting Hall I |
Congress
session 5: Induced abortion – An update |
|
| Chair: V. Prilepskaya (Russia) – J. Bitzer
(Switzerland) |
|||
| Book of abstracts | |||
| 14:00 | The challenge of post-abortion contraception – K.
Gemzell (Sweden) |
IS-53 | |
| 14:20 | Follow-up after induced abortion: current practice and
evidence – C. Fiala (Austria) |
IS-54 | |
| 14:40 | Access to safe abortion: legal and other obstacles
– M. Vekemans (United Kingdom) |
IS-55 | |
| 15:00 | A comparison of two dosages of buccal Misoprostol®
following Mifepristone® for early medical abortion – T. Tsereteli (Georgia) |
FC-35 | |
| 15:15 | Expanding options for in-the-mouth Misoprostol®
administration following Mifepristone® in medical abortion – B. Winikoff (USA) |
FC-36 | |
|
|
|||
| 14:00 – 15:30 |
Panorama Hall |
||
| 14:00 | Late Breaking News | ||
| Estetrol: a new estrogen in the pill? – H.
Coelingh Bennink (The Netherlands) |
|||
| 14:30 | Best Poster Session | ||
|
|
|||
| 14:00 – 15:30 |
Hall IV |
Forum
3: What is required/minimal criteria/ what should be examined before prescribing |
Book of abstracts |
| D. Apter (Finland) – A. Glasier (UK) | IS-57 | ||
|
|
|||
| 14:00 – 15:30 | Club E | Society
Session 6: Italian Society of Contraception (in English) |
|
| Chair: A. Volpe (Italy) – G.B. Melis (Italy) | |||
| Book of abstracts | |||
| Prevalence of contraceptive use in Italy: comparison
with European countries – G. Benagiano (Italy) |
SS6-01 | ||
| Contraception without bleeding. Attitude of Italian
women – F. Fruzzetti (Italy) |
SS6-02 | ||
| Changing contraceptive needs in different life stages
– V. Bruni (Italy) |
SS6-03 | ||
| Therapeutical effects of hormonal contraceptives –
P.G. Crosignani (Italy) |
SS6-04 | ||
|
|
|||
| 15:30 – 16:00 | Congress Hall | Keynote
Lecture 3 |
|
| Chair: S. Randall (UK) | |||
| New developments in contraception – R. Sitruk-Ware
(USA) |
|||
|
|
| Scientific
programme in detail |
|||
| Wednesday,
April 30 |
Thursday,
May 1 |
Friday,
May 2 |
Saturday,
May 3 |
| 08:30 – 10:00 | 10:30
– 12:00 |
12:15 – 13:15 | 13:30 –
16:00 |
16:30 – 18:00 |
|
complete final announcement (1,509 mB) |
|
